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Epithelial-to-mesenchymal transitionThe epithelial-to-mesenchymal transition (EMT) is a program of cellular development associated with loss of
cell–cell contacts, a decreased cell adhesion and substantial morphological changes. Besides its importance for
numerous developmental processes, EMT has also been held responsible for the development and progression
of tumors and formation of metastases. The inﬂuence of the cytokine transforming growth factor β1 (TGF-β1)
induced EMT on structure, migration, cytoskeletal dynamics and long-term correlations of the mammalian
epithelial cell lines NMuMG, A549 andMDA-MB231 was investigated with time-resolved impedance analysis.
The three cell lines show important differences in concentration dependency, cellular morphology and
dynamics upon their response to TGF-β1. A549 cells and the non-tumor mouse epithelial cell line NMuMG
show a substantial change in morphology mirrored in stepwise changes of their phenotype upon cytokine
treatment. Impedance based measurements of micromotility reveal a complex dynamic response to TGF-β1
exposure which leads to a transient increase in ﬂuctuation amplitude and long-term correlation. These
changes in ﬂuctuation amplitude are also detectable for MDA-MB231 cells, whereas the long-term correlation
remains unvaried. We were able to distinguish three time domains during EMT. Initially, all cell lines display
an increase in micromotion lasting 4 to 9 h termed transitional state I. This regime is followed by transitional
state II lasting approximately 20 h, where cellular dynamics are diminished and, in case of the NMuMG cell
line, a loss of cell–cell contacts occurs. Finally, the transformation into the mesenchymal-like phenotype
occurs 24–30 h after exposure to TGF-β1.ce Sensing; TGF-β, Transform-
al transition; DFA, Detrended
y, Tammannstrasse 6, 37077
551 39 14411.
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The epithelial-to-mesenchymal transition (EMT) is a common
process inside the human body that permits a polarized epithelial cell
to undergo multiple biochemical and morphological changes that
eventually produce a mesenchymal cell [1]. This phenotype displays
enhanced migratory propensity, metastatic potential, resistance to
apoptosis, and increased production of extracellular matrix proteins.
The EMT plays an important role during embryogenesis and wound
healing [1,2] but has also been linked to the development and
progression of tumors and the formation of metastases, like in breast
cancer [3]. The increasing metastatic potential, invasiveness and
motility of cancer cells are important and malign consequences
induced by this transition process [4]. A well known stimulating agent
of EMT is the transforming growth factor-β1 (TGF-β1), a multi-functional cytokine, which binds to speciﬁc transmembrane serine/
threonine kinase receptors that exhibit a heteromeric structure.
The receptor formation between two TGF-β type I (TβR-I) and two
TGF-β type II (TβR-II) receptors leads to the activation of TβR-I
by phosphorylation via TβR-II. This in turn results in a variety of
downstream signaling effects like phosphorylation of a protein family
called Smad (= small mother against decapentaplegic). Besides this
major signaling cascade, other signaling pathways like the MAPK
and PI3/Akt pathway are activated or inﬂuenced [5] and regulate a
tremendous number of different biological processes like cell pro-
liferation, differentiation and apoptosis [6]. There is evidence that
TGF-β has a suppressing inﬂuence on cells at early tumor stages,
whereas during later tumor development, it exerts a prometastatic
impact, contributed by the epithelial-to-mesenchymal transition [7].
Recently, the same trend has been described not only for mammary
glands but also liver tissue [8]. Due to its tumor suppressing effects by
inhibition of cell proliferation and the induction of a controlled cell
death on the one hand and its tumor promoting effects on the other
hand [9], the impact of TGF-β on different cell lines has been studied
extensively [10–12]. The investigation of 18 different human and
mouse cell lines and their response to TGF-β1 shows that an induced
EMT is only a rare event in vitro, which is proven to take place in the
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tubular epithelial cell line MCT [11]. The complex process of EMT
involves a loss of epithelial cell polarity, dissolution of the cell–cell
contacts, and a rearrangement of the cytoskeleton, leading to the
pronounced formation of stress ﬁbers.
The time line of events has, however, been only sparsely addressed
so far [12–14]. It has been found that TGF-β induces a rapid
reorganization of the actin cytoskeleton, ﬁrst resulting in membrane
rufﬂing at the cell edges, and eventually leading to formation of stress
ﬁbers if TGF-β exposure persisted [15,16]. The immediate TGF-β
induced alterations of the actin cytoskeleton have been attributed to
activation of Rho GTPases, Rac, CDC42, and RhoA, which control cell
motility and invasive phenotypes by regulating organization of actin
ﬁlaments [17]. Rho-like GTPases are found to regulate both the
protrusive and contractile forces required for cell migration, through
actin polymerization, depolymerization, and contractility produced
by myosin-based motors acting on actin ﬁlaments [18]. Importantly,
RhoA can also inhibit cell movement by stimulating the assembly of
stress ﬁbers and associated focal adhesions [19]. It has been shown
that expression of tropomyosins in metastatic cells results in stress
ﬁbers and reduces cell motility [20]. The study of Xie et al. [12]
demonstrates that within the ﬁrst hour after addition of TGF-β the
expression of multiple genes that play key roles in regulating cell
cycle progression are suppressed. At 6 and 24 h, TGF-β was shown
to enhance the expression of multiple genes involved in cell shape
regulation and cell adhesion.
Albeit, molecular evidence is accumulating that TGF-β exposure
produces an intricate dynamic response of epithelial cells, which can
roughly be divided into an active early state and a latemesenchymal-like
state in which cells display less motility but form stress ﬁbers and focal
contacts, no functional study exists that provides quantitative data of
EMT dynamics.
In this study, the dynamic effects of TGF-β1 on the mammalian cell
lines NMuMG, A549 and MDA-MB231, owning different metastatic
potentials, were examined by means of Electric Cell-Substrate Imped-
ance Sensing (ECIS) in a time-resolved, concentration-dependent and
non-invasive manner [21]. Impedance analysis is able to detect subtle
changes in cell–cell as well as cell–substrate interactions [22] and
provides furthermore temporal information about cellular motion and
structural alterations [23–26]. Noise of the impedance was analyzed by
means of detrended ﬂuctuation analysis (DFA) and computation of
variance providing information about cellular dynamics mirrored in
long-term correlations of vertical collective motility [27,28]. We found
that exposure of NMuMG and A549 cells to TGF-β1 results initially in an
increased micromotility, displaced by a rather silent phase with a
decaying transepithelial resistance for NMuMG cells, indicative of
dissolution of cell–cell contacts, and eventually leading to the ﬁnal
mesenchymal-like state (N24 h) with pronounced stress ﬁbers and a
ﬁbroblast-like structure. In this ﬁnal statemicromotion and impedance
are minimal. Additionally, epithelial and mesenchymal markers are
expressed at the same time. Interestingly, for MDA-MB231 cells a
transient increase of ﬂuctuation amplitude is observable, but in com-
parison to A549 and NMuMG cells the variance remains elevated.
Additionally, no increased long-term correlation is detectable for MDA-
MB231 cells indicating that these cells show no organized activation
upon cytokine treatment.
2. Materials and methods
2.1. Cells, reagents and antibodies
Mouse mammary epithelial cell line NMuMG and human lung
epithelial cell line A549 were purchased from American Tissue Culture
Collection (ATCC,Manassas, VA). Humanmammary gland epithelial cell
line MDA-MB231 was kindly provided by Prof. Dr. Stauber (Molecular
and cellular oncology, University of Mainz). All cell lines were culturedas recommended by ATCC. The NMuMG cells are cultivated in
Dulbecco's modiﬁed Eagles medium with 4.5 g/l glucose and 2 mM L-
glutamine (PAA Laboratories GmbH, Cölbe, Germany), non essential
amino acids NEA (100 μg/ml), 1 mM sodium pyruvate and 10 μg/ml
insulin. A549 and MDA-MB231 cells are grown in the same medium
like the NMuMG cell line without insulin. The recombinant human
transforming growth factor-β1 (TGF-β1) was purchased from Invitro-
gen (Karlsruhe, Germany), as well as the Alexa546 conjugated
phalloidin. DAPI (4′,6-Diamidino-2-phenylindol) and Alexa Fluor488-
conjugated goat-anti-mouse IgG1 antibody were obtained from BD
Biosciences (Heidelberg, Germany). The polyclonal IgG1 mouse anti-
body for the tight junctions' protein ZO-1 was purchased from Zymed
GmbH (Munich, Germany).
2.2. Fluorescence microscopy
Alterations of the cytoskeleton and the integrity of the cell–cell
contacts under TGF-β1 treatment were visualized by immunostaining
and ﬂuorescence microscopy. For this purpose, the cells were grown
on petri dishes and treated with 10 ng/ml of TGF-β1 for different time
intervals of 1, 6, 12, 24 or 48 h and compared to untreated reference
samples. After rinsing the cells twice with PBS, a−20 °C cold acetone/
methanol mixture (1:1 vol.%) was used to ﬁxate the cells (10 min
incubation time at−20 °C). Thereafter cells were washed twice with
PBS and stained with the speciﬁc staining solution according to the
manufacturer's protocol. Alexa Fluor 546 phalloidin (Invitrogen,
Paisley, UK) was used to stain F-actin. DNA staining was carried out
with 4′-6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich, Seelze),
whereas cell–cell contacts were labeled with polyclonal IgG1 mouse
antibody (Zymed GmbH, Munich) followed by incubation with Alexa
Fluor488-conjugated goat-anti-mouse IgG1 antibody (BD Bioscience,
Heidelberg, Germany). For F-actin and DNA labeling, incubation times
of 30 and 15 min with the staining solutions were chosen. The in-
cubation time to stain cell–cell contacts was 1 h for each step. After
staining, cells were washed twice with PBS. For examination an
upright microscope (Olympus BX51, 20× or 40× water immersion,
Germany) or a confocal laser scanning microscope (LSM 710, Zeiss,
Germany) were used.
2.3. Fluorescence activated cell sorting
For analyzation of the cell cycle distribution of NMuMG cells,
ﬂuorescence activated cell sorting was performed. Therefore 100,000
NMuMG cells were diluted in 500 μl PBS (Phosphate buffered saline)
and added to 3 ml ice-cold ethanol. Then cells were centrifuged 5 min
at 4 °C. After air-drying, the cell pellet was diluted in 500 μl PBS and
50 μl RNAse (1 mg/ml) and 25 μl propidiumiodide (1 mg/ml) were
added to stain the cells. After an incubation time of 30 min at room
temperature the measurements were performed.
2.4. Impedance spectroscopy and micromotion analysis
The cells were seeded onto gold electrodes of 8W1E arrays (Ibidi,
Martinsried, Germany) in 300 μl culture medium supplemented with
100 U/ml penicillin and 50 μg/ml streptomycin (100,000 NMuMG
cells, 100,000 MDA-MB231 cells or 150,000 A549 cells). The arrays
were placed in an incubator adjusted to 37 °C and 5% CO2, and time
resolved impedance measurements were started. After a 24 h time
interval for adhesion and spreading of the cells on the gold electrodes
(diameter of 250 μm), either medium or the cytokine TGF-β1 was
added in fresh culture medium resulting in a ﬁnal concentration of 5,
10 or 15 ng/ml. In some experiments synchronization of NMuMG cells
by serum depletion for 22 h before addition of medium/TGF-β1 was
realized. The impact of synchronization for NMuMG cells has been
investigated by FACS analysis (Suppl. Table 2).
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sured at the end of the experiment 48 h after addition of the cytokine.
Fig. 1A shows a typical impedance spectrum of a conﬂuent cell mono-
layer exhibiting a barrier resistance Rb of 3 Ω cm2, a capacitance of
Cm of 4 μF/cm2 and an α value of 2.4 Ω0.5cm in comparison to an
uncovered electrode. The long proliferation time ensures a conﬂuent
coverage of the electrodes (Fig. 1B). By ﬁtting an area contactmodel as
schematically depicted in Fig. 1C to the data [26,29], we were able to
quantify the density of cell–cell contacts (Rb), the impedance in the
cleft between the cells and their substratum represented by the
parameter α –which is a direct measure for the distance of the cells to
the substrate – and the membrane capacity (Cm) as a function of cell
morphology (Fig. 1). For A549 and MDA-MB231 cells no frequency
sweeps were analyzed, as these cell lines do not express tight
junctions, which limits the applicability of the area contact model.
Time series of impedanceﬂuctuations |Z|were subject to detrended
ﬂuctuation analysis (DFA) and computation of variance analysis.
Therefore, the normalized impedance |ZNorm| (normalized to the time
point of TGF-β1 addition) after stimulation with TGF-β1 was analyzed
in comparison to untreated samples. After applying a sliding window
of 250 points (with an increment of one) to the time-resolved imped-
ance, the arithmetical mean in each of these windows is subtracted
from the central point of the original dataset to remove long-term
drifts due to proliferation or cell death. In the next step, variance is
determined in moving boxes of a size of 1000 points (with an
increment of one) and plotted as a function of time. From these plots,
the duration of increased impedance ﬂuctuations τ after TGF-β1
addition, as well as themean variancesσ2 in this period are calculated.
For untreated samples or samples where no increased ﬂuctuation is
detectable, the full 5750 points (13.5–17.0 h) were used to calculate
the mean variance values.
DFA analysis was carried out according to Peng et al. [30,31],
where the datasets of length N are integrated and split up in l boxes
with the box size n. In each box the linear trend was subtracted and
the variance F(n) was determined calculating the difference between
the original data y(k) and the subtracted trend u(k) (Eq. (1)).
F nð Þ =
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1
N
∑
N
k=1
y kð Þ−u kð Þð Þ2
s
: ð1Þ
After plotting F(n) versus n in a ln(F(n))–ln(n) diagram, the slope
of the applied linear ﬁt gives direct information about the correlation
of the analyzed system as exemplarly shown for simulated datasets of
fractional Brownian motion (Fig. 2). As well as for variance analysis,
the time interval of increased ﬂuctuation after cytokine addition and
the time afterwards, where only small ﬂuctuations occur, are analyzedFig. 1. (A) Simulated impedance spectrum |Z(ω)| of a covered (▲) and uncovered (●) electr
bar 100 μm (C) Simpliﬁed equivalent circuit diagram to describe the measured impedance (
the electrode-medium interface; Rb: barrier resistance between cells; α: representing the rseparately. Overall, 7000 points (15.5–18 h) after TGF-β1 addition
were analyzed in each measurement.
3. Results
3.1. Impact of TGF-β1 on cell morphology and dynamic parameters
Fig. 3 illustrates the morphological changes of all three cell lines
in response to cytokine exposure using ﬂuorescence microscopy.
NMuMG and A549 (Fig. 3) cells transform from an ordered epithelial
organization to ﬁbroblast-like morphology upon treatment with
TGF-β1, whereas no signiﬁcant change in cellular morphology is
detectable for MDA-MB231 cells (Fig. 3I/J). Fluorescence microscopy
of NMuMG cells reveals (ZO-1 immunoﬂuorescence) a loss of tight
junctions (Fig. 3C/D) and formation of stress ﬁbers giving the cell a
ﬁbroblast-like shape after the transition (Fig. 3A/B). A549 cells also
show changes in shape and the number of stress ﬁbers is increased
during cytokine stimulation (Fig. 3E/F) in accordance with previous
ﬁndings [11]. In contrast to the NMuMG cell line, A549 [32] and
MDA-MB231 cells [33] do not form tight junctions in monolayers
(Fig. 3G and K).
We carried out time-resolved impedance spectroscopy of the EMT
in order to capture the dynamic structural alterations of the transition
such as changes of cell shape, cell–substrate distance and cell–cell
contacts as a function of TGF-β1 concentration without interference
from staining. For this purpose cells were cultured on ultrasmall
electrodes as described in Section 2.4.
The dynamic properties of adherent cells during EMTare assessed by
noise analysis of time-resolved impedance measurements. Shape
ﬂuctuations, membrane rufﬂing, dynamic annihilation and reformation
of adhesion sites are usually responsible for the additional impedance
noise produced by adherent living cells. Since the impedance depends
on the current ﬂowing through and underneath adherent cells and in
between cells, substrate ﬂuctuations mirror temporal changes in cell–
cell, aswell as cell–substrate contacts. These assumptions are supported
by simulating temporal ﬂuctuations in h, the distance between cells and
the substrate, and inserting them in the contact model of Lo and Ferrier
[29] to quantify the ramiﬁcations on the impedance (Suppl. Fig. 1). In
brief, an increase of the cell–substrate distance decreases the overall
impedance.
Fig. 4A shows exemplarily the dynamic response of NMuMG cells
cultured on ECIS electrodes to addition of TGF-β1 as a function of time
and cytokine concentration (5–15 ng/ml), after subtracting a long-term
trend from the data as described in the experimental Section 2.4 for
further visibility. The addition of cytokine is set to time point t=0. The
corresponding variance is plotted in Fig. 4B emphasizing that the
increase in motility mirrored in enhanced impedance ﬂuctuations isode (diameter: 250 μm). (B) Phase-contrast image of cell-covered ECIS electrode, scale
Rbulk: resistance of medium; CPE: constant phase element, describing the impedance at
esistance in the cleft between cells and substrate; Cm: membrane capacity).
Fig. 2. (A) Simulated ﬂuctuation of white noise (−, αDFA=0.5), Brownianmotion ( , αDFA=1.5) and fractional Brownianmotion with visibly increasing ﬂuctuations ( , αDFA=2.0).
(B) Detrended ﬂuctuation analysis of time series shown in (A) using same color coding. The higher the slope, the longer the correlation. The root-mean-square ﬂuctuation is plotted
against the length of boxes n in a ln–ln diagram. The slope of the linear ﬁt (αDFA) is a measure for the long-term correlations of the cell system [30,31].
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is clearly concentration dependent but levels off at a TGF-β1
concentration of 15 ng/ml. Below a TGF-β1 concentration of 2.5 ng/ml
we could not detect the elevatedmicromotility. Table 1 and Suppl. Table
1 summarize σ2 for the investigated cell lines under various conditions.
After addition of 5 ng/ml toNMuMGcells,σ2 increases 3.3-fold (without
serum depletion) and 2.3-fold (22 h serum depletion) in comparison to
untreated samples (Table 1). The duration of increased ﬂuctuations is
essentially identical for all TGF-β1 concentrations (5 to 7 h) and does
also not depend on serum depletion. FACS analysis of serum depleted
cells reveals a much higher percentage of cells in the G0/G1 state in
comparison to unsynchronized and subconﬂuent samples, whereas no
signiﬁcant difference in comparison to a conﬂuent cell layer is
detectable. The addition of culture medium after the synchronization
stepdoesnot change the cell cycle status signiﬁcantlywithin theﬁrst 6 h
(Suppl. Table 2). In conclusion, although cell synchronization may alter
the cell cycle distribution of NMuMG cells, it had no effect on the
stimulatory impact of TGF-β1as far asdynamics are concerned. The timeFig. 3. Fluorescence images illustrating TGF-β1 induced shape changes of NMuMG (A to D), A
(10 ng/ml) for 24 h. Images (A), (B), (E), (F), (I) and (J) display F-actin staining with Alexa
ﬁbers is indicated by white arrows. (C), (D), (G), (H), (K) and (L) show Alexa488 conjugated
bars: 50 μm.interval of increased ﬂuctuation is followed by a period where no
elevated ﬂuctuations are detectable represented by a variance that is
comparable to untreated cells (Fig. 4).
Fig. 5 shows the corresponding analysis of impedance ﬂuctuations
representing micromotion of A549 cells after medium or TGF-β1
addition. Essentially, the same behavior as for NMuMG cells is found.
After an initial phase in which the cytokine treated cells ﬂuctuate in
a concentration dependent manner, a silent phase follows that is
characterized by small scale ﬂuctuations comparable to those found
for untreated cells (Suppl. Table 1).
Generally, treatment of the human lung epithelial cell line A549
with 5 ng/ml TGF-β1 did not result in a signiﬁcant change of σ2
(Table 1). A549 showed considerably increased ﬂuctuations after
stimulation with 10 ng/ml TGF-β1 leading to a 3.6-fold increase of the
variance and at 15 ng/ml which results in a 12-fold higher ﬂuctuation
amplitude. For A549 cells treated with 10 ng/ml TGF-β1, the increased
impedance noise persists for approximately 5 h, whereas for 15 ng/ml
this period lasts about 9 h.549 (E to H) andMDA-MB231 cells (I to L) without (−) and with (+) TGF-β1 treatment
Phalloidin546 and staining of the nucleus with DAPI. The increased formation of stress
mouse anti-ZO-1 staining of the cell–cell contacts and DAPI labeling of the nucleus. Scale
Fig. 4. (A) Time resolved and detrended impedance data of 100,000 NMuMG cells
(no serum depletion) seeded on a circular gold electrode (diameter of 250 μm) and
recorded at an excitation frequency of 4 kHz after the addition of (●) 0, ( ) 5, ( ) 10
or ( ) 15 ng/ml TGF-β1 frombottom to top. For better visibility the curves are arbitrarily
shifted in the y-direction. (B)Moving variance analysis of the corresponding impedance
ﬂuctuations in (A) using the same color coding. The dashed line indicates the time point
where a transition from transitional state I to transitional state II occurs (time point for a
treatment with 15 ng/ml TGF-β1).
Fig. 5. Time resolved and detrended impedance data of 150,000 A549 cells recorded at
an excitation frequency of 15 kHz (A) after the addition of (●) 0, ( ) 5, ( ) 10 or ( )
15 ng/ml TGF-β1 from bottom to top. For better visibility the curves are arbitrarily
shifted in the y-direction. (B) Time resolved variance analysis of the corresponding
impedance ﬂuctuations in (A). The dashed line separates transitional state I for a
concentration of 15 ng/ml TGF-β1 from transitional state II.
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necessary to induce changes of σ2 lasting 4–8 h after cytokine treat-
ment (Table 1). After this period the ﬂuctuations remain elevated in
comparison to that of untreated samples and samples with 5 ng/ml
TGF-β1 (Fig. 6 and Suppl. Table 1). Additionally, MDA-MB231 cells
display the highest variances of impedanceﬂuctuations before and after
TGF-β1 treatment, which most likely reﬂects an increased motility
indicating the high metastatic potential of these cells (Table 1). In
the following, we refer to the time interval with increased impedance
ﬂuctuations as the transitional state I.
3.2. Impact of TGF-β1 on cell–cell contact and cell–substrate distance
Apart from micromotility, ECIS also allows to monitor various
cell-speciﬁc parameters such as cell–cell contacts, represented byTable 1
Variances of the impedance ﬂuctuations after cytokine addition to NMuMG, A549 and
MDA-MB231 cells. The time τ in brackets depicts the duration of transition state I after
TGF-β1 addition. The variance σ2 is the mean variance of the normalized impedance
averaged over the time τ (after addition of 5 ng/ml, 10 ng/ml and 15 ng/ml TGF-β1,
respectively). In case of untreated samples (medium addition) and for samples without
an increased noise, 5750 points in the time interval from 13.5 to 17.0 h were analyzed.
Only impedance values 40 min after cytokine/medium addition were considered to
ensure equilibration of the cellular system. For NMuMG cells serum depletion of 22 h
was performed as indicated (ser. depl.). Each measurement was repeated at least three
times. Values are means±SD.
σ2Medium
(×10−5)
σ25ng/ml
(×10−5)
σ210ng/ml
(×10−5)
σ215ng/ml
(×10−5)
NMuMG 1.3±0.3 4.3±1.9
(τ=5 h)
6.2±2.6
(τ=6 h)
7.4±2.6
(τ=6 h)
NMuMG
(ser. depl.)
1.5±0.6 3.4±1.6
(τ=7 h)
9.1±2.2
(τ=5 h)
8.3±7.9
(τ=7 h)
A549 0.9±0.5 0.9±0.4 3.2±0.4
(τ=5 h)
12.0±6.0
(τ=9 h)
MDA-MB231 5.9±0.9 5.9±0.8 21.8±10.0
(τ=4 h)
16.4±3.2
(τ=8 h)the barrier resistance Rb and cell–substrate distance, mirrored in the
parameter α, simultaneously. For this purpose subsequent frequency
sweeps are recorded and subject to ﬁtting the parameters of an
equivalent circuit which models a conﬂuent monolayer on an
electrode (Fig. 1). The area contact model was ﬁrst developed by
Giaever and Keese and extended to more complicated cell geometry
by Lo and Ferrier [26,29]. All static parameters in Table 2 are obtained
from frequency sweeps (Fig. 7) recorded at the ﬁnal mesenchymal-like
state (48 h after cytokine addition). Generally, exposure of NMuMGFig. 6. Time resolved and detrended impedance data of 100,000 MDA-MB231 cells
recorded at an excitation frequency of 4 kHz (A) after the addition of (●) 0, ( ) 5, ( )
10 or ( ) 15 ng/ml TGF-β1 from bottom to top. For better visibility the curves are
arbitrarily shifted in the y-direction. (B) Time resolved variance analysis of the
corresponding impedance ﬂuctuations in (A). The dashed line separates transitional
state I for a concentration of 10 ng/ml TGF-β1 from transitional state II.
Table 2
Data obtained from ﬁtting the ECIS model introduced by Lo and Ferrier [29] to
impedance spectra from Fig. 7 for NMuMG cells treatedwith 0 ng/mL, 5 ng/ml, 10 ng/ml and
15 ng/ml TGF-β1 (spectra taken after 48 h incubation time). The barrier resistance Rb is a
direct measure for the integrity of the cell–cell contacts. Determination of the width of the
cells before and after treatment of the cells is used to convertα values into the distance of the
cells to the substrate (Eq. (2)). Cm provides information about the membrane capacity of the
cells and electrode coverage. Eachmeasurementwas repeated at least three times. Values are
means±SD.
NMuMG Rb (Ω cm2) α (Ω0.5 cm) Distance h (nm) Cm (μF/cm2)
Medium 3.0±0.6 3.33±0.45 27±4 1.3±0.1
5 ng/ml TGF-β1 1.0±0.3 3.09±0.05 32±1 1.0±0.1
10 ng/ml TGF-β1 0.7±0.5 2.47±0.35 50±7 1.1±0.2
15 ng/ml TGF-β1 0.9±0.3 2.58±0.01 46±0 1.0±0.1
Fig. 8. Time resolved and normalized barrier resistance Rb, Norm (normalized to the Rb
value before TGF-β1 addition) for NMuMG cells obtained from time resolved frequency
sweeps after the addition of (●) 0 and ( ) 5 ng/ml TGF-β1 (t=0).
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than found for untreated cells. We attribute this decrease of Rb from
3.0±0.6 Ω cm2 to values around 1 Ω cm2 and lower to the loss of cell–
cell contacts during EMT. This assumption is supported by staining of
the tight junction protein ZO-1 before (Fig. 3C) and after (Fig. 3D)
treatment of cells with 10 ng/ml of TGF-β1 for 24 h. For A549 [32] and
MDA-MB231 cells [33], no frequency sweeps were analyzed as the
area contact model is only applicable to cells, which form signiﬁcant
cell–cell contacts (Fig. 3G and K).
In case of NMuMG cells, a decrease in α, which represents the
impedance in the cleft between the cells and their substratum (Eq. (2)), is
observed at TGF-β1 concentrations of 10 ng/ml and 15 ng/ml leading to
higher values for the distances h of the cells to the substrate (W is the
width or radius of a single cell, ρ the resistivity of the cell medium in the
cleft between cells and substrate) [29].
α = 0:5⋅W⋅
ﬃﬃﬃ
ρ
h
r
ð2Þ
For NMuMG cells an elongation and increase in size of the cells
after the EMT were considered for the calculation of h and serve as
an input parameter for the dielectric contact model of Lo and Ferrier
[29]. By analyzing ﬂuorescent and light microscopy pictures, we
assume a width to length ratio for NMuMG cells before treatment of
15×19 μm2 and a corresponding ratio after treatment of 15×25 μm2.
In addition, the membrane capacity Cm decreases in a concentration
dependent manner for NMuMG cells, which is most likely due to
stress ﬁber formation and a concomitant decrease of membrane area.Fig. 7. Impedance spectra |Z(ω)| (dots) and the corresponding nonlinear regression (lines)
of 100,000 NMuMG cells (22 h serum depletion time) treated with TGF-β1. The spectra
were recorded at least 48 h after the addition of the cytokinewith concentrations of (●) 0,
( ) 5, ( ) 10 or ( ) 15 ng/ml TGF-β1 from bottom to top.The loss of cell–cell contact as derived from measurements of
the barrier resistance Rb obtained from time resolved frequency sweeps
(Fig. 8) sets in roughly 10 h after cytokine addition (5 ng/ml TGF-β1, red
trace) and ends within the next 20 h, whereas Rb of the corresponding
untreated control (black trace) remains unaffected but shows even a
small increase. Staining of the tight junction protein ZO-1 visualizes the
time-dependent dissolution of cell–cell contacts, which sets in already
12 h after cytokine addition (Fig. 9A–J). The actin staining indicates that
detectable morphological changes occur not until 12 h after TGF-β1
addition. Finally, after complete loss of barrier resistance due to lateral
separation of the cells (24–30 h after cytokine addition), themesenchy-
mal-like state associated with massive morphological alterations of
epithelial cells is reached. This takes another 10–24 h until all cells are
transformed into ﬁbroblast-like cells. The time interval in which
dissolution of tight junctions occurs is referred to transitional state II.
Subsequently, the ﬁnal mesenchymal-like state is reached.
3.3. Long-term correlations of cells in response to TGF-β1
Long-term correlations of the impedance noise can be best
deduced from detrended ﬂuctuation analysis as recommend for
non-stationary signals [27]. While σ2 denotes the strength of
collective motion, the αDFA value reﬂects the emergence of correla-
tions and complex dynamics and can be regarded as a measure of
cellular dynamics. Periodogram analysis of impedance ﬂuctuations of
living cells reveal a power law behavior f−β with βN2.0, which is
commonly interpreted as fractional Brownian motion (βN1) as
opposed to fractional Gaussian motion βb1 [34,35]. This ﬁnding is
important for interpretation of αDFA values and the associated Hurst
coefﬁcient H, which is related to αDFA (α=H+1 for βN1.0) and is an
indicator for long-memory time series. The collective shape ﬂuctua-
tions, reorganization of the cytoskeleton and opening/closing of
adhesion bonds are the most important factors for higher αDFA values
and therefore Hurst coefﬁcients [36], implying an increased long-
memory effect of the system. Regardless of the treatment of the cells,
all αDFA values are signiﬁcantly higher than 1.5, verifying that cell
dynamics are strongly correlated in time. In case of untreated samples,
the correlated system might be explained by communication of
synchronous neighboring cells via their cell–cell contacts. These
interactions are responsible for contact inhibition of cells and their
synchronous entry to the G1/G0-phase of the cell-cycle [37]. Exposure
to TGF-β1 changes the autocorrelation in a cell-speciﬁc fashion. αDFA
values obtained from the impedance time series of NMuMG cells
during the time of elevated ﬂuctuation, for both 0 and 22 h serum
depletion time, increase at a concentration higher than 5 ng/ml
TGF-β1, up to values larger than 1.8 indicative of substantial long-
memory effects (TGF-β1,Table 3). After this time period (αDFA_A),
the αDFA decline (αDFA_B) and reach values even smaller than obtained
Fig. 9. Fluorescence images of NMuMG cells treated with 10 ng/mL TGF-β1 for 1, 6, 12, 24 and 48 h showing the time-resolved dissolution of the tight junctions (Alexa488 conjugated
mouse anti-ZO-1, A–E) and the concomitant structural reorganization of the actin cytoskeleton (Alexa Phalloidin546, F–J). The nucleus was stained with DAPI. Scale bars: 50 μm.
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are similar, except for the fact, that a higher cytokine concentration
(10 ng/ml TGF-β1) is necessary to reach αDFA values of more than 1.8.
In contrast, αDFA values of MDA-MB231 cells are completely
unaffected by addition of the cytokine supporting the anticipated
small impact of the cytokine on this highly metastatic cell line
(Table 3), which is also reﬂected in the circumstance that no
signiﬁcant morphological changes occur (Fig. 3I/J). These results
also indicate that high variance does not necessarily correlate with
higher αDFA values.
4. Discussion
Generally, we found that the dynamic response of NMuMG, A549
and MDA-MB231 cells to addition of TGF-β1 can be divided into
three distinct time periods (Fig. 10). Initially after administration of
TGF-β1 all cell lines show an increase in micromotion amplitude,
i.e. variance of impedance ﬂuctuations, which lasts around 4–9 h.
Since the elevated variances drop down afterwards, we refer to this
time regime as the transitional state I. This increase of impedance
ﬂuctuations can be interpreted in terms of structural/adhesive
alterations of cells [38,39]. The signiﬁcant concentration-dependent
increase of the impedance ﬂuctuations for all cell lines reﬂected in
the corresponding variance after cytokine addition (Table 1) points
clearly toward increased membrane rufﬂing and higher activity of the
contractile apparatus of the cells as well as remodeling of the actin
cytoskeleton [12]. A comparable concentration-dependent effect has
been shown by Edlund et al. [16], who observed membrane rufﬂing
of PC-3U only at TGF-β concentrations of 10 ng/ml and higher. The
elevation of Rho GTPases directly after cytokine stimulation has
already been reported [40]. Bhowmick et al. [41] showed that the Rho-
associated protein kinase playing an important role for regulation of
the actin cytoskeleton is activated/phosphorylated up to 6 h afterTable 3
Data obtained by detrended ﬂuctuation analysis for untreated (medium) and TGF-β1 treate
increased noise in the impedance signal after cytokine addition, the αDFA is calculated for
pronounced ﬂuctuation (αDFA_B). The corresponding time regimes are taken from Table 1. I
noise 7000 points (15.5–20 h) from |ZNorm| time series were used to calculate the αDFA values
ensure equilibration of the cellular system. For NMuMG cells serum depletion of 22 h was p
Values are means±SD.
αDFA medium αDFA_A 5 ng/ml αDFA_B 5 ng/ml
NMuMG 1.70±0.01 1.83±0.10 1.63±0.06
NMuMG (ser. depl.) 1.70±0.08 1.86±0.02 1.64±0.06
A549 1.65±0.03 1.64±0.02 –
MDA-MB231 1.62±0.01 1.60±0.06 –cytokine stimulation. Zheng et al. [42] reported a rapid induction of
RhoA and CDC42 signaling after TGF-β1 addition, whereas a longer
incubation time with the cytokine is necessary to induce stress ﬁber
formation. In case of A549 and NMuMG cells, generally an immediate
rise in αDFA values takes place due to TGF-β1 treatment within
transitional state I supporting the idea that signaling cascades like the
Smad and the MAPK pathway are activated simultaneously. From the
investigations of Lamouille and Derynck [13], we conclude that
protein synthesis is not responsible for the temporal high ﬂuctuation
amplitude lasting up to 9 h, as an increased protein synthesis was
observed by the authors for NMuMG cells only after 12 h of TGF-β
treatment. Activation of signaling cascades leads to changes of
nonlinear dynamics inside the cells including the organized modula-
tion of the actin cytoskeleton, the shape of the cell, the cell–substrate
interactions, as well as the cell–cell contacts. The start of the “EMT
program” with a predeﬁned order of alterations and signals increases
the temporal correlation of the analyzed cell system (Table 3). The
external stimulus results in a higher correlated system, and the
involved G1/S inhibition of NMuMG cells under TGF-β1 treatment
supports this increase [43]. MDA-MB231 cells are known for a strong
autocrine TGF-β1 signaling [44] reﬂecting the high motility and
invasiveness of this cell line, even in the absence of external stimuli.
Additionally, no structural alterations of this cell line are observable
(Fig. 3I/J). These ﬁndings explain why an external addition of the
cytokine does not lead to an increase in the correlation reﬂected by
αDFA values (Table 3). Consequently, by means of detrended
ﬂuctuation analysis, we gained insight into the state of the phenotype
and the metastatic potential of the investigated cell lines. This
correlation between αDFA or β and metastatic potential has been
previously investigated by Lovelady et al. [23] and Tarantola et al. [28].
For NMuMG cells alterations in cytoskeletal organization are ﬁrst
detectable 12 h after TGF-β1 addition (Fig. 9F–J). This is in good
accordance with the results from Bakin et al. [20], who observed ad (5 ng/ml, 10 ng/ml and 15 ng/ml) NMuMG, A549 and MDA-MB231 cells. In case of an
the time τ of ﬂuctuation (αDFA_A) referred to as transitional state I and the time after
n case of untreated samples (medium addition) and for samples without an increased
. The points for calculation were taken about 40 min after cytokine/medium addition to
erformed as indicated (ser. depl.) Each measurement was repeated at least three times.
αDFA_A 10 ng/ml αDFA_B 10 ng/ml αDFA_A 15 ng/ml αDFA_B 15 ng/ml
1.88±0.03 1.64±0.03 1.79±0.03 1.63±0.01
1.90±0.02 1.67±0.01 1.85±0.03 1.71±0.04
1.85±0.15 1.58±0.02 1.82±0.06 1.58±0.05
1.63±0.05 1.64±0.04 1.65±0.05 1.64±0.02
Fig. 10. Schematic image of the Epithelial-to-mesenchymal transition visualizing the occurring structural changes and the detectable alterations in the measured impedance signals
according to our results.
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reorganizational processes involve signaling cascades via Rho GTPases
and/or Smad signaling [16,41]. Once stress ﬁber assembly associated
with the formation of strong focal adhesions is initialized, A549 and
NMuMG cells show dynamics resembling those of untreated samples
(Suppl. Table 1). The increase in cellular adhesion during transitional
state II reduces cell-shape ﬂuctuations, the alterations of cell-substrate
distance and the correlation of the cellular system in comparison
to transitional state I. Le Clainche and Carlier [45] explained that in
response to RhoA signaling, a maturation of focal complexes into focal
adhesions occurs. Interestingly, for MDA-MB231 cells the σ2 values
decrease during transitional state II, but still remain elevated in
comparison to untreated samples. This result can be explained by the
fact that MDA-MB231 cells do not show stress ﬁber formation after
cytokine addition. Furthermore, Bakin et al. [20] reported that due to
constitutively activation of Ras-ERK signaling tropomyosin expression
is decreased and stress ﬁbers are disrupted. Consequently, no com-
plete attenuation of the impedance ﬂuctuations due to lack of stress
ﬁber formation occurs.
Subsequently, within transitional state II conﬂuent NMuMG cell
monolayers display a decrease in impedance that we could unequiv-
ocally attribute to loss of cell–cell contacts modeling time-resolved
frequency sweeps of complex impedance recordings (Table 2). The
observed loss of cell–cell contacts can be rationalized by the EMT
during which the expression of tight junction proteins is down-
regulated [46]. The phosphorylation of Par6which is important for the
maintenance of cell polarity and tight junctions results, via interaction
with ligase Smurf1, in a degradation of RhoA [47]. This in turn leads to
the loss of tight junction proteins. Hence, the alternating current can
more easily pass the cell layer leading to a decrease in the static
cellular parameter Rb (Fig. 8). The time-resolved observation of the
ﬂuorescent labeled tight junction protein ZO-1 indicates that only
after 12 h a disruption of cell–cell contacts begins. This process is
completed within the next 12 to 36 h (Fig. 9A–E) being in accordance
with studies from Maeda et al. [48] who observed a degradation of
ZO-1 after 12 h of incubation time. Consequently, transitional state II
ﬁnalizes usually within 24–30 h after exposure to the cytokine, which
is in good agreement with the results by Lamouille and Derynck
reporting an elongation of the cells between 24 and 36 h after
cytokine addition [13]. Not until cell–cell-contacts disrupt we observe
severe morphological changes toward a ﬁnal mesenchymal-like state
for NMuMG cells (Fig. 9F–J). Cells adopt a ﬁbroblast-like shape and
express pronounced stress ﬁbers associatedwith strong focal contacts.
These changes in cell shape and structure have been conﬁrmed by
ﬂuorescencemicroscopy (Figs. 3 and 9) and are supported by the static
cellular parameters obtained from impedance spectroscopy 48 h after
cytokine addition (Table 2).Whereas the interaction betweenNMuMGcells is mainly reﬂected in Rb, the average distance between the cells
and their substratum is mirrored in α. α is primary inﬂuenced at
concentrations higher than 10 ng/ml, while changes in Rb are clearly
detectable already at 5 ng/ml. The investigation of TGF-β1-regulated
gene expression in NMuMG cells showed that a high number of
genes are inﬂuenced depending on the time of exposure [12]. Hence, if
time-dependent effects take place, a concentration-dependency is
supposable. The reversibility of the EMT via withdrawal of TGF-β [42]
supports the hypothesis of several states between the two extremes,
the epithelial and the mesenchymal-like state. The description of a
“metastable phenotype”byKlymkowsky and Savagner [49] shows also
the wide spectrum of an induced epithelial-to-mesenchymal transi-
tion, as well as the expression of epithelial and mesenchymal markers
at the same time [50]. Hence, the concentration-dependent changes
of σ2 values and static cellular parameters can be explained with a
gradual change of the phenotype and show the different susceptibility
of the investigated cell lines.5. Conclusions
Our ﬁndings suggest dividing the EMT into three subsequent steps,
the initial state referred to as the transitional state I, the transitional
state II, and the ﬁnal mesenchymal-like state. While in transition state I
micromotility of cells is considerably increased as mirrored in larger
variances of impedance ﬂuctuations, stress-ﬁber formation and the
completion of severe morphological changes like cell–cell contact
dissolution for NMuMG cells occur predominately in transitional state
II with minimal micromotion. Additionally, according to our results,
cells in a higher metastatic state like the MDA-MB231 cell line re-
spond to TGF-β1 differently compared to cells with a lowermetastatic
potential like NMuMG or A549 cells. Whereas in cytokine-treated
NMuMG and A549 cells a higher amplitude and time correlation of
micromotion is induced as a response to the selective activation of
speciﬁc signaling pathways and the start of the “EMT program”, the
per se highly metastatic MDA-MB231 cells show elevated impedance
ﬂuctuations but an unaffected time correlation. The processes inside
these cells are obviously extremely disordered and are less regulated
than in non-cancerous cell lines.
In summary, we have – for the ﬁrst time – established a functional
assay of the EMT addressing time evolution of the process as a
function of TGF-β1 concentration and metastatic potential. To our
knowledge, this is the ﬁrst time gradual changes in cellular dynamics
and morphology during EMT are overall quantiﬁed in a non-invasive
and concentration-dependent manner at such high time resolution.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbamcr.2011.07.016.
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